Viemed Healthcare (VMD) Change in Account Payables (2018 - 2026)
Viemed Healthcare's (VMD) quarterly Change in Account Payables came in at $1.6 million in Q1 2026, up 34.52% YoY from $1.2 million in Q1 2025, and up 649.31% on a QoQ basis from -$288000.0 in Q4 2025.
Viemed Healthcare (VMD) Change in Account Payables (2018 - 2026) Analysis & Trends
Viemed Healthcare (VMD) has 9 years of Change in Account Payables data on file, last reported at $1.6 million in Q1 2026.
- Quarterly Change in Account Payables rose 34.52% year-over-year to $1.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $885000.0 (down 6.55% YoY) and the FY2025 annual result came in at $479000.0, up 33.43% from the prior year.
- Change in Account Payables grew to $1.6 million in Q1 2026, from -$288000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.6 million in Q1 2026 to a low of -$1.1 million in Q2 2023.
- A 5-year average of $73117.6 and a median of $224000.0 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables soared 394.74% — and 2023, when it plunged 604.02%.
- Tracing VMD's Change in Account Payables over 5 years: stood at -$351000.0 in 2022, then tumbled by 72.08% to -$604000.0 in 2023, then surged by 35.76% to -$388000.0 in 2024, then increased by 25.77% to -$288000.0 in 2025, then jumped by 649.31% to $1.6 million in 2026.
- The last three Change in Account Payables figures came in at $1.6 million (Q1 2026), -$288000.0 (Q4 2025), and -$831000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Viemed Healthcare | 328.34 Mn | 317.66 Mn | 45.05 Mn | 490,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 490,000.00 |
| Jun 30, 2026 | 490,000.00 |
| Mar 31, 2026 | 1.58 Mn |
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | -288,000.00 |
| Dec 31, 2025 | -288,000.00 |
| Sep 30, 2025 | -831,000.00 |
| Sep 30, 2025 | -831,000.00 |
| Jun 30, 2025 | 422,000.00 |
| Jun 30, 2025 | 422,000.00 |
| Mar 31, 2025 | 1.18 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | -388,000.00 |
| Dec 31, 2024 | -388,000.00 |
| Sep 30, 2024 | -367,000.00 |
| Sep 30, 2024 | -367,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Jun 30, 2024 | 526,000.00 |
| Mar 31, 2024 | 588,000.00 |
| Mar 31, 2024 | 588,000.00 |